Cancerous Lung Algorithms:
CEA, CA15.3, Cyfra 21.1, SCC, NSE, ProGRPOvarian Cancer Algorithms:
CA 125, HE-4, ROMALiver Cancer Algorithms:
AFPGeneral Use Algorithms:
CA19.9, β-HCG, tPSA, fPSA, CA72.4, Calcitonin, S-100, Thyroglobuline (Tg)Early detection of Cancer can really make a difference. Book here.
Are You at risk? Don’t wait!
Book your at - home testing now.
3 simple steps for early detection of Cancer:
step
01
Order your product
step
02
Schedule the at home visit with a phlebotomist
step
03
Review your results with a qualified credentialed health care professional on a virtual video visit.
OXFORD STUDY, OUR SCREENING CAME OUT ON TOP
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.
It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus
Why Concierge Cancer Screening
Apart from being backed by the Oxford University studies our one of a kind cancer screening is capable of detecting 18 different cancer types across 26 specified categories. This enables early detection of cancer upto 2 years before any other system can catch it.
The possibility of having cancer is debilitating for anyone. But by taking the right steps to find cancer early on can help you be more in control. The earlier cancer can be detected, better the chances of survival and recovery.
In fact if diagnosed early survival and recovery chances are 4 times higher than when diagnosed at a later stage.
How it works
Book a sample collection
After booking your package all you need to do is to schedule an appointment with one of our phlebotomists, who will collect the blood sample right from the comfort of your home.
The Screening:
The sample will be sent for processing and our system does the screening by running the 16 panels and 24 algorithms.
Virtual Video Visit:
After the screening is done you will receive an email to schedule a Virtual Video Visit with one of our Oncologists who will explain and share the results with you.
Cancer Diagnosis and Staging with Tumor Markers
A tumor marker is anything present in or produced by cancer cells or other cells of the body in response to cancer or certain benign (noncancerous) conditions that provides information about a cancer, such as how aggressive it is, what kind of treatment it may respond to, or whether it is responding to treatment. Tumor markers have traditionally been proteins or other substances that are made at higher amounts by cancer cells than normal cells. These can be found in the blood, urine, stool, tumors, or other tissues or bodily fluids of some patients with cancer.
ProGRP: Pro-gastrin-releasing peptide
ProGRM is a more stable biochemical precursor of GRP and a member of the bombesin family of peptides which is especially produced by the neuroendocrine origin Small Cell Lung Cancer(SCLC). Circulating proGRP levels serve as a reliable marker in patients with SCLC and is the most sensitive marker for discriminating SCLC from benign diseases of the lung.
NSE: Neuron Specific Enolase
Neuron-specific enolase (NSE) is a substance that has been detected in patients with certain tumors, namely: neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, endocrine tumors of the pancreas, and melanoma and is known to be a cell specific isoenzyme of the glycolytic enzyme enolase.
CEA: Carcinoembryonic antigen
CEA stands for carcinoembryonic antigen. It is a protein found in the tissues of a developing baby. CEA levels normally become very low or disappear after birth. Healthy adults should have very little or no CEA in their body. This test measures the amount of CEA in the blood, and sometimes in other body fluids. A high level of CEA can be a sign of certain types of cancers. These include cancers of the colon and rectum, prostate, ovary, lung, thyroid, or liver.
CA 15-3: Cancer Antigen 15-3
The cancer antigen 15-3 (CA 15-3) test is mainly used to monitor response to breast cancer treatment and to help watch for breast cancer recurrence. Elevated levels of CA 15-3 are also associated with cancers of the ovary, lung, and prostate, as well as noncancerous conditions such as benign breast or ovarian disease, endometriosis, pelvic inflammatory disease, and hepatitis. Pregnancy and lactation also can raise CA 15-3 levels.
CYFRA 21-1: Cytokeratin fragment 21-1
Cytokeratins are epithelial markers whose expression is not lost during malignant transformation. CYFRA 21-1 is a fragment of cytokeratin 19 that is typically associated with epithelial cell cancers, including Non-small cell lung cancer (NSCLC), and is typically associated with the squamous cell lung cancer (SQLC) type.
SCC: Squamous cell carcinoma
SCC antigen (SCCA) represents a subfraction of tumor-associated antigens related to squamous cell carcinoma and is used as a serum tumor marker for squamous cell carcinoma of the head and neck, lung (including esophagus), and other types of SCC and is reported as a target gene for the detection of tumor cells in peripheral blood in cervical cancer.
CA 19-9: Carbohydrate antigen 19-9
Carbohydrate antigen 19-9, is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.
CA 125: Cancer Antigen 125
A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. This test may be used to monitor certain cancers during and after treatment. In some situations, the test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease.
CA 72-4: Cancer Antigen 74-4
CA72-4 is a tumor marker (TM) that has been found elevated in a variety of human adenocarcinomas, with reported sensitivities of up 50% and overall specificity of over 95%. Using the DRG TM-CA72-4 assay, we quantified the abnormality rate of TM CA72-4 compared with current FDA-approved TM in various cancers.
AFP: Alpha-fetoprotein
Alpha-fetoprotein (AFP) is used as a tumor marker to help detect and diagnose cancers of the liver, testicles, and ovaries.
HE4: Human epididymis secretory protein 4
A protein found on cells that line the lungs and reproductive organs, such as the ovaries. HE4 may be found in higher than normal amounts in patients with some types of cancer, including ovarian epithelial cancer.
ROMA: Risk of Ovarian Malignancy Algorithm (CA125 + HE4)
The risk of ovarian malignancy algorithm (ROMA) incorporates cancer antigen 125 (CA125), human epididymal protein 4 (HE4), and menopausal status to assign women that present with an adnexal mass into a high-risk or low-risk group for finding an ovarian malignancy.
tPSA: Total Prostate-specific antigen
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in the blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.
fPDA: Free Prostate-specific antigen
Free prostate-specific antigen (PSA) tests can help detect signs of prostate cancer. They measure the level of a biomarker that may indicate the condition. PSA is a substance that the prostate gland produces. Levels vary according to a person's age and other factors. The amount of the protein prostate-specific antigen (PSA) in the blood that is not attached to other proteins.
β-hCG: Beta Subunit human chorionic gonadotropin
A serum test used as a tumor marker for testicular carcinoma. Beta-HCG levels are never found in normal men. When the presence of β-HCG is detected in serum it always indicates a malignancy. Also called: β-HCG, beta-HCG, beta chain HCG.
Calcitonin
This test measures the level of calcitonin in your blood. Calcitonin is a hormone made by your thyroid, a small, butterfly-shaped gland located near the throat. If too much calcitonin is found in the blood, it may be a sign of a type of thyroid cancer called medullary thyroid cancer (MTC).
S-100
S100 is an acidic-calcium-binding protein, composed as a heterodimer of two isomeric subunits alpha and beta and was first described in cells of neuroendocrine origin. It plays an important role in various cellular processes such as cell differentiation and proliferation and interacts with the tumor suppressor gene p53. S100 is also present in melanoma cells and its immunohistochemical detection is widely used in the histopathological diagnosis of malignant melanoma.
Thyroglobuline (Tg)
Thyroglobulin (Tg) is a protein made by the thyroid gland. Tg can also be produced by certain types of thyroid cancer. The thyroglobulin test is a type of tumor marker test used to measure the amount of Tg in the blood. Most often, doctors order Tg testing to evaluate the effectiveness of thyroid cancer treatment or to monitor for a recurrence of thyroid cancer after treatment is completed. Tg levels may also be measured to help diagnose certain non-cancerous conditions of the thyroid.
Terms & ConditionsPrivacy Policy Copyright © 2022 Concierge Cancer Screening. All Rights Reserved